A review of the management of patients after percutaneous coronary intervention.
The exponential increase in the numbers of percutaneous coronary interventions (PCIs) has led to many clinicians having to care for post-PCI patients. We review the management of early problems seen in post-PCI patients, such as vascular access site complications, contrast nephropathy, drug-induced thrombocytopaenia and chest pain. The management of possible restenosis and the use of stress testing are discussed. The complications from dual antiplatelet therapy are addressed. The prognosis of the post-PCI patient, the implications of co-existent heart failure and the newer technologies of implantable defibrillator and cardiac resynchronisation therapy are reviewed. We conclude by emphasising the importance of secondary prevention by risk factor modification as well as the communication between the clinician and the cardiologist.
Wong
E M L
EM
Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China. edmondwong@hotmail.com
Wu
E B
EB
Chan
W W M
WW
Yu
C M
CM
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000379:methods; D002637:Chest Pain / Q000209:etiology; D023903:Coronary Restenosis / Q000175:diagnosis; D017147:Defibrillators, Implantable; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011379:Prognosis; D013921:Thrombocytopenia / Q000209:etiology
D010975:Platelet Aggregation Inhibitors